Insider Trading Activity For ChemoCentryx, Inc. (NASDAQ:CCXI)
Roger C Lucas , Director of ChemoCentryx, Inc. (NASDAQ:CCXI) reportedly Sold 2,250 shares of the company’s stock at an average price of 10.07 for a total transaction amount of $22,657.50 SEC Form
Insider Trading History For ChemoCentryx, Inc. (NASDAQ:CCXI)
On 10/1/2012 Thomas J Schall, CEO, sold 15,000 with an average share price of $11.53 per share and the total transaction amounting to $172,950.00.View SEC Filing
On 10/1/2012 Susan M Kanaya, CFO, sold 3,971 with an average share price of $11.89 per share and the total transaction amounting to $47,215.19.View SEC Filing
On 10/4/2012 Roger C Lucas, Director, sold 1,893 with an average share price of $11.47 per share and the total transaction amounting to $21,712.71.View SEC Filing
On 11/6/2012 Bvf Partners L P/Il, Major Shareholder, bought 40,000 with an average share price of $12.00 per share and the total transaction amounting to $480,000.00.View SEC Filing
On 1/17/2013 Markus J Cappel, Treasurer, sold 2,700 with an average share price of $11.16 per share and the total transaction amounting to $30,132.00.View SEC Filing
On 2/4/2013 Juan C Jaen, SVP, sold 3,875 with an average share price of $11.69 per share and the total transaction amounting to $45,298.75.View SEC Filing
On 2/6/2013 Roger C Lucas, Director, sold 3,857 with an average share price of $11.52 per share and the total transaction amounting to $44,432.64.View SEC Filing
Analyst Ratings For ChemoCentryx, Inc. (NASDAQ:CCXI)
These are 1 Hold Rating, 2 Buy Ratings .
The current consensus rating for ChemoCentryx, Inc. (NASDAQ:CCXI) is Buy (Score: 2.67) with a consensus target price of $11.00 , a potential (9.34% upside)
Analyst Ratings History For ChemoCentryx, Inc. (NASDAQ:CCXI)
- On 8/9/2016 J P Morgan Chase & Co Reiterated Rating Buy with a price target of $11.00
- On 2/21/2017 JMP Securities Initiated Coverage of rating Mkt Outperform to Outperform
- On 3/15/2017 Cowen and Company Reiterated Rating Hold
Recent Trading Activity for ChemoCentryx, Inc. (NASDAQ:CCXI)
Shares of ChemoCentryx, Inc. closed the previous trading session at 10.06 down -0.63 -5.89% with 144,148 shares trading hands.